SSH - TRI-CITIES INC. — History
CCN 442016 | 3-year financial timeline | COVID resilience: 42/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+4.1%
Revenue CAGR (3yr)
9.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $19M | $20M | +7.0% | +4.1% |
| Operating Expenses | $15M | $14M | $18M | +29.7% | +11.7% |
| Operating Margin | 21.0% | 24.9% | 9.0% | -63.8% | -34.5% |
| Net Income | $4M | $5M | $2M | -61.3% | -31.8% |
| Licensed Beds | 33 | 35 | 35 | +0.0% | +3.0% |
| Total Patient Days | 11,397 | 11,465 | 11,161 | -2.7% | -1.0% |
| Medicare Day % | 34% | 27% | 24% | -11.8% | -15.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 42/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.3% ($19M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.1%
This Hospital
+7.6%
State Avg
Latest Margin
9.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $21M | 3.0% |
| FY2024 (proj) | $22M | -3.0% |
| FY2025 (proj) | $22M | -9.0% |